Robert, Caroline <br/><br/>
Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  06 2018 
 - 1668-1674 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2017.75.6270  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Agents, Immunological--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cohort Studies<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Skin Neoplasms--drug therapy